King Fish Media Announces Website Launch for CoLucid Pharmaceuticals
King Fish Media Announces Website Launch for CoLucid Pharmaceuticals
King Fish Media, a digital and content management marketing agency, announced today that it has launched a new website on behalf of its client, CoLucid Pharmaceuticals, Inc., (NASDAQ: CLCD), at www.colucid.com. CoLucid is a Phase 3 clinical-stage biopharmaceutical company developing lasmiditan oral tablets for the acute treatment of migraine in adults.
"CoLucid's objective is to provide key information to three core stakeholder groups: prospective patients, physicians and the investment community. Each stakeholder group has a different set of information needs," said King Fish president Cam Brown. "King Fish specializes in creating websites that deliver clear information paths for diverse user groups and provide visitors with actionable information to ensure their experience is as complete as possible. CoLucid is utilizing a combination of illustration, infographics and textual treatments to guide visitors through their unique information needs."
King Fish was engaged by CoLucid for site development, launch and delivery of dynamic content on an ongoing basis. King Fish's work centered on bringing a strategic focus to content management and brand identity for CoLucid.
"We retained King Fish based on their strong track record of creating effective public-facing digital content that highlighted complex pharmaceutical information," said CoLucid's President and Chief Executive Officer, Thomas P. Mathers. "King Fish took an innovative company and product with intricate audience segmentation and designed a website that presents CoLucid's key messages and corporate materials in a clear and compelling manner. King Fish demonstrated a strong understanding of our business, technology and lasmiditan development program, and helped us create a website that effectively communicates with each of our key stakeholder groups."
"It's more than a simple content integration. It's about helping a client look at digital media differently," Brown said.
––
About King Fish Media
The company develops integrated campaigns that create an emotional connection between clients and their customers and prospects. Each program is designed to deliver measurable results based on real-world marketing objectives. To effectively deliver branded content, King Fish helps clients Own Their Media Channel® by strategically creating media platforms including branded editorial content, responsive web sites, social media campaigns, eBooks, white papers, infographics, online video, as well as live and virtual events. King Fish has created profit-generating programs for companies including Affinion, Ameriprise, Bank of America, Boston Market, C&S Wholesale Grocers, Cengage Learning, CoLucid, Commvault, IBM, Janus Capital, Keurig Green Mountain, New York Life, Precision Medicine Group, Zappos, and others. For more information, visit www.kingfishmedia.com.
About CoLucid Pharmaceuticals, Inc.
CoLucid was founded in 2005 and is developing lasmiditan oral tablets for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of headache pain associated with migraine in adults in emergency room and other urgent care settings.
King Fish Media, a digital and content management marketing agency, announced today that it has launched a new website on behalf of its client, CoLucid Pharmaceuticals, Inc., (NASDAQ: CLCD), at www.colucid.com. CoLucid is a Phase 3 clinical-stage biopharmaceutical company developing lasmiditan oral tablets for the acute treatment of migraine in adults.
"CoLucid's objective is to provide key information to three core stakeholder groups: prospective patients, physicians and the investment community. Each stakeholder group has a different set of information needs," said King Fish president Cam Brown. "King Fish specializes in creating websites that deliver clear information paths for diverse user groups and provide visitors with actionable information to ensure their experience is as complete as possible. CoLucid is utilizing a combination of illustration, infographics and textual treatments to guide visitors through their unique information needs."
King Fish was engaged by CoLucid for site development, launch and delivery of dynamic content on an ongoing basis. King Fish's work centered on bringing a strategic focus to content management and brand identity for CoLucid.
"We retained King Fish based on their strong track record of creating effective public-facing digital content that highlighted complex pharmaceutical information," said CoLucid's President and Chief Executive Officer, Thomas P. Mathers. "King Fish took an innovative company and product with intricate audience segmentation and designed a website that presents CoLucid's key messages and corporate materials in a clear and compelling manner. King Fish demonstrated a strong understanding of our business, technology and lasmiditan development program, and helped us create a website that effectively communicates with each of our key stakeholder groups."
"It's more than a simple content integration. It's about helping a client look at digital media differently," Brown said.
––
About King Fish Media
The company develops integrated campaigns that create an emotional connection between clients and their customers and prospects. Each program is designed to deliver measurable results based on real-world marketing objectives. To effectively deliver branded content, King Fish helps clients Own Their Media Channel® by strategically creating media platforms including branded editorial content, responsive web sites, social media campaigns, eBooks, white papers, infographics, online video, as well as live and virtual events. King Fish has created profit-generating programs for companies including Affinion, Ameriprise, Bank of America, Boston Market, C&S Wholesale Grocers, Cengage Learning, CoLucid, Commvault, IBM, Janus Capital, Keurig Green Mountain, New York Life, Precision Medicine Group, Zappos, and others. For more information, visit www.kingfishmedia.com.
About CoLucid Pharmaceuticals, Inc.
CoLucid was founded in 2005 and is developing lasmiditan oral tablets for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of headache pain associated with migraine in adults in emergency room and other urgent care settings.
King Fish Media, a digital and content management marketing agency, announced today that it has launched a new website on behalf of its client, CoLucid Pharmaceuticals, Inc., (NASDAQ: CLCD), at www.colucid.com. CoLucid is a Phase 3 clinical-stage biopharmaceutical company developing lasmiditan oral tablets for the acute treatment of migraine in adults.
"CoLucid's objective is to provide key information to three core stakeholder groups: prospective patients, physicians and the investment community. Each stakeholder group has a different set of information needs," said King Fish president Cam Brown. "King Fish specializes in creating websites that deliver clear information paths for diverse user groups and provide visitors with actionable information to ensure their experience is as complete as possible. CoLucid is utilizing a combination of illustration, infographics and textual treatments to guide visitors through their unique information needs."
King Fish was engaged by CoLucid for site development, launch and delivery of dynamic content on an ongoing basis. King Fish's work centered on bringing a strategic focus to content management and brand identity for CoLucid.
"We retained King Fish based on their strong track record of creating effective public-facing digital content that highlighted complex pharmaceutical information," said CoLucid's President and Chief Executive Officer, Thomas P. Mathers. "King Fish took an innovative company and product with intricate audience segmentation and designed a website that presents CoLucid's key messages and corporate materials in a clear and compelling manner. King Fish demonstrated a strong understanding of our business, technology and lasmiditan development program, and helped us create a website that effectively communicates with each of our key stakeholder groups."
"It's more than a simple content integration. It's about helping a client look at digital media differently," Brown said.
––
About King Fish Media
The company develops integrated campaigns that create an emotional connection between clients and their customers and prospects. Each program is designed to deliver measurable results based on real-world marketing objectives. To effectively deliver branded content, King Fish helps clients Own Their Media Channel® by strategically creating media platforms including branded editorial content, responsive web sites, social media campaigns, eBooks, white papers, infographics, online video, as well as live and virtual events. King Fish has created profit-generating programs for companies including Affinion, Ameriprise, Bank of America, Boston Market, C&S Wholesale Grocers, Cengage Learning, CoLucid, Commvault, IBM, Janus Capital, Keurig Green Mountain, New York Life, Precision Medicine Group, Zappos, and others. For more information, visit www.kingfishmedia.com.
About CoLucid Pharmaceuticals, Inc.
CoLucid was founded in 2005 and is developing lasmiditan oral tablets for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of headache pain associated with migraine in adults in emergency room and other urgent care settings.
King Fish Media, a digital and content management marketing agency, announced today that it has launched a new website on behalf of its client, CoLucid Pharmaceuticals, Inc., (NASDAQ: CLCD), at www.colucid.com. CoLucid is a Phase 3 clinical-stage biopharmaceutical company developing lasmiditan oral tablets for the acute treatment of migraine in adults.
"CoLucid's objective is to provide key information to three core stakeholder groups: prospective patients, physicians and the investment community. Each stakeholder group has a different set of information needs," said King Fish president Cam Brown. "King Fish specializes in creating websites that deliver clear information paths for diverse user groups and provide visitors with actionable information to ensure their experience is as complete as possible. CoLucid is utilizing a combination of illustration, infographics and textual treatments to guide visitors through their unique information needs."
King Fish was engaged by CoLucid for site development, launch and delivery of dynamic content on an ongoing basis. King Fish's work centered on bringing a strategic focus to content management and brand identity for CoLucid.
"We retained King Fish based on their strong track record of creating effective public-facing digital content that highlighted complex pharmaceutical information," said CoLucid's President and Chief Executive Officer, Thomas P. Mathers. "King Fish took an innovative company and product with intricate audience segmentation and designed a website that presents CoLucid's key messages and corporate materials in a clear and compelling manner. King Fish demonstrated a strong understanding of our business, technology and lasmiditan development program, and helped us create a website that effectively communicates with each of our key stakeholder groups."
"It's more than a simple content integration. It's about helping a client look at digital media differently," Brown said.
––
About King Fish Media
The company develops integrated campaigns that create an emotional connection between clients and their customers and prospects. Each program is designed to deliver measurable results based on real-world marketing objectives. To effectively deliver branded content, King Fish helps clients Own Their Media Channel® by strategically creating media platforms including branded editorial content, responsive web sites, social media campaigns, eBooks, white papers, infographics, online video, as well as live and virtual events. King Fish has created profit-generating programs for companies including Affinion, Ameriprise, Bank of America, Boston Market, C&S Wholesale Grocers, Cengage Learning, CoLucid, Commvault, IBM, Janus Capital, Keurig Green Mountain, New York Life, Precision Medicine Group, Zappos, and others. For more information, visit www.kingfishmedia.com.
About CoLucid Pharmaceuticals, Inc.
CoLucid was founded in 2005 and is developing lasmiditan oral tablets for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of headache pain associated with migraine in adults in emergency room and other urgent care settings.
King Fish Media, a digital and content management marketing agency, announced today that it has launched a new website on behalf of its client, CoLucid Pharmaceuticals, Inc., (NASDAQ: CLCD), at www.colucid.com. CoLucid is a Phase 3 clinical-stage biopharmaceutical company developing lasmiditan oral tablets for the acute treatment of migraine in adults.
"CoLucid's objective is to provide key information to three core stakeholder groups: prospective patients, physicians and the investment community. Each stakeholder group has a different set of information needs," said King Fish president Cam Brown. "King Fish specializes in creating websites that deliver clear information paths for diverse user groups and provide visitors with actionable information to ensure their experience is as complete as possible. CoLucid is utilizing a combination of illustration, infographics and textual treatments to guide visitors through their unique information needs."
King Fish was engaged by CoLucid for site development, launch and delivery of dynamic content on an ongoing basis. King Fish's work centered on bringing a strategic focus to content management and brand identity for CoLucid.
"We retained King Fish based on their strong track record of creating effective public-facing digital content that highlighted complex pharmaceutical information," said CoLucid's President and Chief Executive Officer, Thomas P. Mathers. "King Fish took an innovative company and product with intricate audience segmentation and designed a website that presents CoLucid's key messages and corporate materials in a clear and compelling manner. King Fish demonstrated a strong understanding of our business, technology and lasmiditan development program, and helped us create a website that effectively communicates with each of our key stakeholder groups."
"It's more than a simple content integration. It's about helping a client look at digital media differently," Brown said.
––
About King Fish Media
The company develops integrated campaigns that create an emotional connection between clients and their customers and prospects. Each program is designed to deliver measurable results based on real-world marketing objectives. To effectively deliver branded content, King Fish helps clients Own Their Media Channel® by strategically creating media platforms including branded editorial content, responsive web sites, social media campaigns, eBooks, white papers, infographics, online video, as well as live and virtual events. King Fish has created profit-generating programs for companies including Affinion, Ameriprise, Bank of America, Boston Market, C&S Wholesale Grocers, Cengage Learning, CoLucid, Commvault, IBM, Janus Capital, Keurig Green Mountain, New York Life, Precision Medicine Group, Zappos, and others. For more information, visit www.kingfishmedia.com.
About CoLucid Pharmaceuticals, Inc.
CoLucid was founded in 2005 and is developing lasmiditan oral tablets for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of headache pain associated with migraine in adults in emergency room and other urgent care settings.
Let's talk
Let's talk
Let's talk
info@kingfishmedia.com
978 . 745 . 4140
info@kingfishmedia.com
978 . 745 . 4140
info@kingfishmedia.com
978 . 745 . 4140
Come aboard
Come aboard
Come aboard
Swing by
Swing by
Swing by
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston
900 Cummings Center
Suite 307-V
Beverly, MA 01915
Directions From Boston